Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 136

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Alzheimer's disease: Effects of β-amyloid on mitochondria

Tillement, Laurent, Lecanu, Laurent, Papadopoulos, Vassilios · 2011 · Mitochondrion

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.mito.2010.08.009

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 66

  1. Alexeyev, 2004, Mitochondrial DNA and aging, Clin. Sci., 107, 355, 10.1042/CS20040148 · DOI
  2. Arispe, 1993, Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum, Proc. Natl Acad. Sci. USA, 90, 567, 10.1073/pnas.90.2.567 · DOI · Paper page
  3. Bannwarth, 2006, Rapid identification of unknown heteroplasmic mutations across the entire human mitochondrial genome with mismatch-specific Surveyor Nuclease, Nat. Protoc., 1, 2037, 10.1038/nprot.2006.318 · DOI
  4. Brown, 2002, Nitric oxide inhibition of mitochondrial respiration and its role in cell death, Free Radic. Biol. Med., 33, 1440, 10.1016/S0891-5849(02)01112-7 · DOI · Paper page
  5. Carney, 1991, Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha- phenylnitrone, Proc. Natl Acad. Sci. USA, 88, 3633, 10.1073/pnas.88.9.3633 · DOI · Paper page
  6. Cataldo, 1994, Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease, Brain Res., 640, 68, 10.1016/0006-8993(94)91858-9 · DOI · Paper page
  7. Chan, 2006, Mitochondrial fusion and fission in mammals, Annu. Rev. Cell Dev. Biol., 22, 79, 10.1146/annurev.cellbio.22.010305.104638 · DOI · Paper page
  8. Csordás, 1999, Quasi-synaptic calcium signal transmission between endoplasmic reticulum and mitochondria, EMBO, 18, 96, 10.1093/emboj/18.1.96 · DOI · Paper page
  9. Davis, 2009, Structure of the amyloid-β (1–42) monomer absorbed to model phospholipid bilayers: a molecular dynamics study, J. Phys. Chem. B, 113, 14480, 10.1021/jp905889z · DOI
  10. Davis, 1997, Mutations in mitochondrial cytosome c oxidase genes segregate with late-onset Alzheimer disease, Proc. Natl Acad. Sci., 94, 4526, 10.1073/pnas.94.9.4526 · DOI · Paper page
  11. Du, 2008, Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease, Nat. Med., 14, 1097, 10.1038/nm.1868 · DOI · Paper page
  12. Engel, 2009, Membrane permeabilization by islet amyloid polypeptide, Chem. Phys. Lipids, 160, 1, 10.1016/j.chemphyslip.2009.03.008 · DOI
  13. Estus, 1997, Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant “apoptotic” pattern of gene induction, J. Neurosci., 17, 7736, 10.1523/JNEUROSCI.17-20-07736.1997 · DOI · Paper page
  14. Ferreiro, 2008, The release of calcium from the endoplasmic reticulum induced by amyloid-beta and prion peptides activates the mitochondrial apoptotic pathway, Neurobiol. Dis., 30, 331, 10.1016/j.nbd.2008.02.003 · DOI · Paper page
  15. Goldsbury, 2008, Oxidative stress increases levels of endogenous amyloid-beta peptides secreted from primary chick brain neurons, Aging Cell, 7, 771, 10.1111/j.1474-9726.2008.00423.x · DOI
  16. Grünblatt, 2009, Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study, J. Psychiatr. Res., 43, 298, 10.1016/j.jpsychires.2008.05.008 · DOI
  17. Guo, 2007, Targeting amyloid-beta in glaucoma treatment, Proc. Natl Acad. Sci. USA, 104, 13444, 10.1073/pnas.0703707104 · DOI · Paper page
  18. Hansson Petersen, 2008, The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae, Proc. Natl. Acad. Sci. USA, 105, 13145, 10.1073/pnas.0806192105 · DOI · Paper page
  19. Hauptmann, 2009, Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice, Neurobiol. Aging, 30, 1574, 10.1016/j.neurobiolaging.2007.12.005 · DOI · Paper page
  20. Hsu, 2009, Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration, Biochim. Biophys. Acta, 1800, 290, 10.1016/j.bbagen.2009.08.003 · DOI
  21. Jaksch, 1995, Screening for mitochondrial DNA (mtDNA) point mutations using nonradioactive single strand conformation polymorphism (SSCP) analysis, Clin. Biochem., 28, 503, 10.1016/0009-9120(95)00035-8 · DOI
  22. Janson, 1999, The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles, Diabetes, 48, 491, 10.2337/diabetes.48.3.491 · DOI · Paper page
  23. Jungbauer, 2009, Preparation of fluorescently-labeled amyloid-beta peptide assemblies: the effect of fluorophore conjugation on structure and function, J. Mol. Recognit., 22, 403, 10.1002/jmr.948 · DOI
  24. Kagan, 2004, Amyloid peptide channels, J. Membr. Biol., 202, 1, 10.1007/s00232-004-0709-4 · DOI · Paper page
  25. Keil, 2004, Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis, J. Biol. Chem., 279, 50310, 10.1074/jbc.M405600200 · DOI · Paper page
  26. Kim, 2002, Amyloid beta peptide induces cytochrome C release from isolated mitochondria, NeuroReport, 13, 1989, 10.1097/00001756-200210280-00032 · DOI · Paper page
  27. Klein, 2002, Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets, Neurochem. Int., 41, 345, 10.1016/S0197-0186(02)00050-5 · DOI · Paper page
  28. Kulic, L., Wollmer, M.A., Rhein, V., Pagani, L., Kuehnle, K., Cattepoel, S., Tracy, J., Eckert, A., Nitsch, R.M., in press. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration. Neurobiol. Aging PMID: 19942317.
  29. Lal, 2007, Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm, Biochim. Biophys. Acta, 1768, 1966, 10.1016/j.bbamem.2007.04.021 · DOI · Paper page
  30. Lapointe, 2009, When a theory of aging ages badly, Cell. Mol. Life Sci., 67, 1, 10.1007/s00018-009-0138-8 · DOI · Paper page
  31. Lecanu, 2009, Caprospinol: moving from a neuroactive steroid to a neurotropic drug, Expert Opin. Investig. Drugs, 18, 265, 10.1517/13543780902762827 · DOI
  32. Lee, 2006, Fidelity of the human mitochondrial DNA polymerase, J. Biol. Chem., 281, 36236, 10.1074/jbc.M607964200 · DOI
  33. Li, 1996, Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells, Brain Res., 738, 196, 10.1016/S0006-8993(96)00733-0 · DOI
  34. Loo, 1993, Apoptosis is induced by beta-amyloid in cultured central nervous system neurons, Proc. Natl Acad. Sci. USA, 90, 7951, 10.1073/pnas.90.17.7951 · DOI · Paper page
  35. Marín, 2000, Beta-amyloid-induced activation of caspase-3 in primary cultures of rat neurons, Mech. Ageing Dev., 119, 63, 10.1016/S0047-6374(00)00172-X · DOI
  36. McAlpine, 2009, Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology, Neurobiol. Dis., 34, 163, 10.1016/j.nbd.2009.01.006 · DOI · Paper page
  37. Minogue, 2003, Activation of the c-Jun N-terminal kinase signaling cascade mediates the effect of amyloid-β on long term potentiation and cell death in hippocampus. A role for interleukin-1 β, J. Biol. Chem., 278, 27971, 10.1074/jbc.M302530200 · DOI
  38. Mironov, 2005, Ca2+]i signaling between mitochondria and endoplasmic reticulum in neurons is regulated by microtubules. From mitochondrial permeability transition pore to Ca2+-induced Ca2+ release, J. Biol. Chem., 280, 715, 10.1074/jbc.M409819200 · DOI
  39. Misumi, 2009, Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy, J. Pathol., 219, 481, 10.1002/path.2618 · DOI
  40. Moreira, 2002, Effect of amyloid beta-peptide on permeability transition pore: a comparative study, J. Neurosci. Res., 69, 257, 10.1002/jnr.10282 · DOI
  41. Morishima, 2001, Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand, J. Neurosci., 21, 7551, 10.1523/JNEUROSCI.21-19-07551.2001 · DOI · Paper page
  42. Murakami, 2009, Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde, Neurobiol. Aging, 30, 325, 10.1016/j.neurobiolaging.2007.07.002 · DOI
  43. Nunomura, 2009, RNA oxidation in Alzheimer disease and related neurodegenerative disorders, Acta Neuropathol., 118, 151, 10.1007/s00401-009-0508-1 · DOI · Paper page
  44. Ohyagi, 2005, Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease, FASEB J., 19, 255, 10.1096/fj.04-2637fje · DOI · Paper page
  45. Parfait, 2000, Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome, Hum. Genet., 106, 236, 10.1007/s004390051033 · DOI · Paper page
  46. Powell, 2000, Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/Amyloid-β binding alcohol dehydrogenase (ABAD), J. Mol. Biol., 303, 311, 10.1006/jmbi.2000.4139 · DOI
  47. Reddy, 2009, Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease, Exp. Neurol., 218, 286, 10.1016/j.expneurol.2009.03.042 · DOI · Paper page
  48. Reddy, 2009, Oxidative stress in diabetes and Alzheimer's disease, J. Alzheimers Dis., 16, 763, 10.3233/JAD-2009-1013 · DOI · Paper page
  49. Rhein, 2009, Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells, Cell. Mol. Neurobiol., 29, 1063, 10.1007/s10571-009-9398-y · DOI · Paper page
  50. Rui, 2006, Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons, J. Neurosci., 26, 10480, 10.1523/JNEUROSCI.3231-06.2006 · DOI · Paper page
  51. Salminen, 2008, Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology, J. Cell. Mol. Med., 12, 2255, 10.1111/j.1582-4934.2008.00496.x · DOI · Paper page
  52. Salminen, 2009, Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defense via pattern recognition receptors, Prog. Neurobiol., 87, 181, 10.1016/j.pneurobio.2009.01.001 · DOI · Paper page
  53. Schipper, 2009, Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment, Neurobiol. Aging
  54. Schmidt, 2008, Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells, Mol. Psychiatry, 13, 953, 10.1038/sj.mp.4002077 · DOI
  55. Sergeant, 2003, Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease, Neuroscience, 117, 293, 10.1016/S0306-4522(02)00747-9 · DOI
  56. Shastry, 1999, Genes and susceptible loci of Alzheimer's disease, Brain Res. Bull., 48, 121, 10.1016/S0361-9230(98)00156-7 · DOI
  57. Sheng, 2009, Inhibition of γ-secretase activity reduces Aβ production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease, Free Radic. Biol. Med., 46, 1362, 10.1016/j.freeradbiomed.2009.02.018 · DOI
  58. Singh, 2009, Possible role of amyloid-beta, adenine nucleotide translocase and cyclophilin-D interaction in mitochondrial dysfunction of Alzheimer's disease, Bioinformation, 3, 440, 10.6026/97320630003440 · DOI
  59. Tillement, 2006, The spirostenol (22R, 25R)-20alpha-spirost-5-en-3beta-yl hexanoate blocks mitochondrial uptake of Abeta in neuronal cells and prevents Abeta-induced impairment of mitochondrial function, Steroids, 71, 725, 10.1016/j.steroids.2006.05.003 · DOI
  60. Volicer, 1990, Involvement of free radicals in dementia of the Alzheimer type: a hypothesis, Neurobiol. Aging, 11, 567, 10.1016/0197-4580(90)90119-K · DOI · Paper page
  61. Wakayama, 2000, Ageing: cloning of mice to six generations, Nature, 407, 318, 10.1038/35030301 · DOI · Paper page
  62. Wang, 2010, Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons, Neurodegener. Dis., 7, 56, 10.1159/000283484 · DOI
  63. Yin, 2005, Abeta25-35 alters Akt activity, resulting in Bad translocation and mitochondrial dysfunction in cerebrovascular endothelial cells, J. Cereb. Blood Flow Metab., 25, 1445, 10.1038/sj.jcbfm.9600139 · DOI
  64. Yu, 2010, Endocytic pathways mediating oligomeric Abeta42 neurotoxicity, Mol. Neurodegener., 17, 5
  65. Zhang, 2009, Hyperphosphorylation of microtubule-associated tau protein plays dual role in neurodegeneration and neuroprotection, Pathophysiology, 16, 311, 10.1016/j.pathophys.2009.02.003 · DOI
  66. Zheng, 2006, The amyloid precursor protein: beyond amyloid, Mol. Neurodegener., 1, 5, 10.1186/1750-1326-1-5 · DOI

Cited by

See all 136

Metadata

Authors
Tillement, L., Lecanu, L., & Papadopoulos, V.
Venue
Mitochondrion
Publisher
Elsevier BV
Published
2011-01
Volume
11
Issue
1
Pages
13-21
ISSN
1567-7249
Cited by
136
References
14
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alzheimer's disease: Effects of β-amyloid on mitochondria. https://app.cochat.ai/papers/10.1016/j.mito.2010.08.009
The paper
Tillement, L., Lecanu, L., & Papadopoulos, V. (2011). Alzheimer's disease: Effects of β-amyloid on mitochondria. Mitochondrion. https://doi.org/10.1016/j.mito.2010.08.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.